Trump/Cook, Nissan weakness, more tariffs and gold - what’s moving markets
In a recent development, AMN Healthcare Services Inc . (NYSE:AMN), a prominent player in healthcare staffing and workforce solutions with a market capitalization of $963 million, announced the retirement of Douglas D. Wheat from his role as the Chairman of the Board of Directors. According to InvestingPro data, the company maintains a Good financial health score despite challenging market conditions, with the stock down over 56% in the past six months. The change took effect on Monday, February 4, 2025, as disclosed in the company’s latest 8-K filing with the U.S. Securities and Exchange Commission.
Wheat’s departure from the board is not associated with any disagreements regarding AMN Healthcare’s operations, policies, or practices. In recognition of his service, the board has honored Wheat with the title of Chairman Emeritus.
Following Wheat’s retirement, the board appointed Mark G. Foletta as the new Chairman. The company has not publicly disclosed any additional changes to its compensatory arrangements for certain officers in connection with this transition.
This leadership change comes at a time when the healthcare industry continues to face significant staffing challenges, highlighting the importance of AMN Healthcare’s services in the market.
The information reported here is based on a press release statement and reflects the latest governance adjustments within AMN Healthcare Services Inc.
In other recent news, AMN Healthcare Services Inc. has been the subject of several analyst reports. JMP Securities reduced their price target for AMN Healthcare to $34, maintaining an outperform rating. This adjustment was due to a revision of the company’s expected earnings before interest, taxes, depreciation, and amortization (EBITDA) for 2025, now forecasted at $235 million. Similarly, BMO Capital Markets also reduced its price target for AMN to $46, reflecting a cautious outlook on operating margins despite the company’s stable trends.
In terms of earnings and revenue, AMN Healthcare recently reported mixed Q3 results. The company’s Q3 revenue was $688 million, surpassing guidance but down 19% year-over-year. Adjusted EBITDA fell 45% from the previous year to $74 million. Despite these figures, certain segments such as Physician Leadership Solutions and Locum Tenens saw growth, indicating potential areas of strength amid the challenging healthcare staffing environment.
These are recent developments for AMN Healthcare, providing investors with the latest insights into the company’s financial outlook. As the healthcare staffing sector continues to face near-term challenges, the company remains optimistic about signs of market stabilization and future growth opportunities.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.